These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7909036)

  • 1. ApoE genotype and Down's syndrome.
    Hardy J; Crook R; Perry R; Raghavan R; Roberts G
    Lancet; 1994 Apr; 343(8903):979-80. PubMed ID: 7909036
    [No Abstract]   [Full Text] [Related]  

  • 2. APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome.
    Deb S; Braganza J; Norton N; Williams H; Kehoe PG; Williams J; Owen MJ
    Br J Psychiatry; 2000 May; 176():468-72. PubMed ID: 10912224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E, Alzheimer's disease and Down's syndrome.
    Prasher VP; Haque MS
    Br J Psychiatry; 2000 Nov; 177():469-70. PubMed ID: 11060007
    [No Abstract]   [Full Text] [Related]  

  • 4. Lower frequency of apolipoprotein E4 allele in an "elderly" Down's syndrome population.
    Cosgrave M; Tyrrell J; Dreja H; Hawi Z; Lawlor BA; Gill M
    Biol Psychiatry; 1996 Oct; 40(8):811-3. PubMed ID: 8894078
    [No Abstract]   [Full Text] [Related]  

  • 5. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing.
    van Gool WA; Evenhuis HM; van Duijn CM
    Ann Neurol; 1995 Aug; 38(2):225-30. PubMed ID: 7654070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome.
    Wisniewski T; Morelli L; Wegiel J; Levy E; Wisniewski HM; Frangione B
    Ann Neurol; 1995 Jan; 37(1):136-8. PubMed ID: 7818249
    [No Abstract]   [Full Text] [Related]  

  • 7. Alzheimer's disease, Down's syndrome, and chromosome segregation.
    Potter H; Geller LN
    Lancet; 1996 Jul; 348(9019):66. PubMed ID: 8691961
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of the APOE alleles impact in Down's syndrome.
    Lambert JC; Pérez-Tur J; Dupire MJ; Delacourte A; Frigard B; Chartier-Harlin MC
    Neurosci Lett; 1996 Dec; 220(1):57-60. PubMed ID: 8977148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The apolipoprotein E genotype and Down's syndrome].
    Rascón Trincado MV; González Sarmiento R; Salazar A-Villalobos V
    Rev Clin Esp; 1997 Oct; 197(10):680-3. PubMed ID: 9424665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia.
    Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Raghavan R; Khin-Nu C; Tyrer S; Day K; Crook R
    Neuroreport; 1994 Dec; 5(18):2583-5. PubMed ID: 7696609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoE2 allele, Down's syndrome, and dementia.
    Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Ragbavan R; Khin-Nu C; Tyner S; Day K; Crook R; Hardy J; Roberts GW
    Ann N Y Acad Sci; 1996 Jan; 777():255-9. PubMed ID: 8624094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onset of dementia is associated with apolipoprotein E epsilon4 in Down's syndrome.
    Schupf N; Kapell D; Lee JH; Zigman W; Canto B; Tycko B; Mayeux R
    Ann Neurol; 1996 Nov; 40(5):799-801. PubMed ID: 8957023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome.
    Sekijima Y; Ikeda S; Tokuda T; Satoh S; Hidaka H; Hidaka E; Ishikawa M; Yanagisawa N
    Eur Neurol; 1998; 39(4):234-7. PubMed ID: 9635475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down's syndrome, longevity, and Alzheimer's disease.
    Harrison P
    Br J Psychiatry; 1993 Feb; 162():276. PubMed ID: 8435713
    [No Abstract]   [Full Text] [Related]  

  • 15. ApoE genotype and Alzheimer's disease in adults with Down syndrome: meta-analysis.
    Prasher VP; Chowdhury TA; Rowe BR; Bain SC
    Am J Ment Retard; 1997 Sep; 102(2):103-10. PubMed ID: 9327086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors.
    McCarron MO; Nicoll JA; Graham DI
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):405-6. PubMed ID: 9728967
    [No Abstract]   [Full Text] [Related]  

  • 17. [Down's syndrome and dementia].
    Parajuá-Pozo JL; Casis-Arguea S
    Rev Neurol; 2000 Jul 16-31; 31(2):126-8. PubMed ID: 10951667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotype.
    Mann DM; Pickering-Brown SM; Siddons MA; Iwatsubo T; Ihara Y; Asami-Odaka A; Suzuki N
    Neurosci Lett; 1995 Aug; 196(1-2):105-8. PubMed ID: 7501233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down's syndrome, longevity, and Alzheimer's disease.
    Prasher VP
    Br J Psychiatry; 1993 May; 162():711. PubMed ID: 8149134
    [No Abstract]   [Full Text] [Related]  

  • 20. Apolipoprotein E allele distribution in parents of Down's syndrome children.
    Avramopoulos D; Mikkelsen M; Vassilopoulos D; Grigoriadou M; Petersen MB
    Lancet; 1996 Mar; 347(9005):862-5. PubMed ID: 8622392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.